Updated Jul 16, 2026
Hamill John P. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $31K. Historical track record: 5/5 stars across 4 tracked purchases.
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★★ (5/5) |
|---|---|
| Total purchases tracked | 4 |
| Purchases with forward-return data | 4 |
| 30-day win rate | 10000% |
| 90-day win rate | 10000% |
| Avg 5-day return | +762.88% |
| Avg 30-day return | +2250.27% |
| Avg 90-day return | +2588.46% |
| Best 30-day return | +3858.27% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-16 | APRE | Aprea Therapeutics, Inc. | A — Grant or award | 10.1K | $0.00 | |
| 2026-02-02 | APRE | Aprea Therapeutics, Inc. | P — Open-market purchase | 5.7K | $0.89 | $5K |
| 2024-10-16 | APRE | Aprea Therapeutics, Inc. | P — Open-market purchase | 50 | $2.46 | $123 |
| 2024-10-15 | APRE | Aprea Therapeutics, Inc. | P — Open-market purchase | 450 | $2.61 | $1K |
Hamill John P. is a corporate insider — currently tracked as SrVP/CFO/Prin Fin & Acct Ofcr. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 6 open-market purchases ($31K) and 0 open-market sales () across all tracked filings.
Across 4 tracked purchases, Hamill John P. averaged +2250.3% avg 30-day return with a 10000% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hamill John P. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.